Richard Ramko is a partner in Ernst & Young's South Florida practice, primarily serving publicly-held and emerging growth companies in the Health Sciences, Biotech and Technology industries.
Ramko has extensive experience serving large, publicly-held companies as well as newly formed start-ups and venture-backed enterprises. Richard has 15 years of experience, including 13 years in public accounting and 2 years in executive level financial positions in private industry and is a certified public accountant in Florida and Tennessee. Some of his current clients include Andrx Corporation, Nabi Biopharmaceuticals, Stiefel Laboratories and SFBC International.
This is an interesting slide. It's the Merck Biotech index. For many years, we used this in our biotech reports and basically back in 1991 what we did was compared the biotech industry to one large pharmaceutical that being Merck. In 1991, Merck had revenues of $8.6 billion compared to total indu...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
